Marc B. Garnick, MD 

Marc B. Garnick, M.D., is the Gorman Brothers Professor of Medicine at Harvard Medical School (HMS) and the Beth Israel Deaconess Medical Center, where he also directs the hospital’s role as a tertiary cancer center for many of its affiliated community cancer centers. He has established initiatives to help underserved patients and families address the non-medical and financial challenges that a cancer diagnosis poses. He completed fellowships at the National Institutes of Health and the Dana-Farber Cancer Institute and is a member of the Dana-Farber/Harvard Cancer Center. Dr. Garnick previously served as Executive Vice President at several biotechnology companies.  

He serves as the editor in chief for the HMS Report on Prostate Diseases and its associated website. He served as the initial academic co-principal investigator for the commonly used prostate cancer drug leuprolide (Lupron). He has received multiple awards including the Distinguished Medical Alumni Service Award from the Perelman School of Medicine, the Jack Colbert Award for Prostate Cancer Research, and the Whittier Health Medical Center Men’s Champion Award. He has recently completed a 10-year tenure as a special governmental advisory member of multiple FDA panels and advisory committees. He currently serves on the boards (scientific and corporate) of several life science companies. He has served on the board of trustees of the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine. He is also a trustee emeritus of Bowdoin College in Brunswick, Maine.